Corinne Epperly

Corinne Epperly, MD, MPH is a prominent leader in the biopharmaceutical industry, currently serving as Co-Founder and CEO of Stealth Newco since February 2024, with ongoing roles as a Board Member at IN8bio and Sastra cell therapy. Previously, Corinne held the position of Chief Operating Officer at CARGO Therapeutics, focusing on next-gen CAR-T cell therapies, and was a Board Member at AVEO Oncology. Corinne's extensive experience includes senior roles at Iovance Biotherapeutics, Vascular Biogenics Ltd., and Bristol-Myers Squibb, where responsibilities encompassed medical strategy, safety management in immuno-oncology, and leading global mergers and acquisitions. Educational achievements include a Doctorate of Medicine from the University of North Carolina School of Medicine and a Masters of Public Health from the University of North Carolina School of Global Public Health.